Nivix Pharmaceuticals Secures WHO-GMP Certification for the First Time

Nivix Pharmaceuticals Limited has received its first WHO-GMP certification, marking a major milestone in meeting international standards for production, quality control, record-keeping, environmental management, and skilled workforce.

With over 68 medicines already strengthening participation in government procurement and export potential, the company has regulatory approval for more than 100 products.

Nivix has also applied to the Securities Board of Nepal to offer shares to the public. Company leadership credits this achievement to their commitment to innovation, quality, and efficiency, highlighting its role in advancing Nepal’s pharmaceutical industry and ensuring safe, effective, and accessible medicines.